Viewing Study NCT01512693


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-04 @ 5:56 PM
Study NCT ID: NCT01512693
Status: COMPLETED
Last Update Posted: 2018-08-29
First Post: 2012-01-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070)
Sponsor: Merck Sharp & Dohme LLC
Organization: